文献速递慢阻肺

CT测量总气道计数与慢阻肺进展风险:基于人群的研究

Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

基于CanCOLD人群队列,纳入从不吸烟者、高危吸烟者及GOLD I-II期慢阻肺患者,分析吸气/呼气CT的总气道计数(TAC)与6年肺功能下降的关系。结果显示GOLD I和II期患者TAC较从不吸烟者降低19%,较高危者降低17%,且TAC与FEV1下降独立相关,提示TAC可能预测慢阻肺进展。

要点

  • GOLD I-II期慢阻肺患者CT总气道计数较从不吸烟者降低19%。
  • TAC与FEV1、FEV1/FVC及支气管舒张反应性关联最强。
  • TAC独立于肺气肿与6年肺功能下降相关(FEV1 P=0.02)。

核心结论

  • TAC可能反映早期/轻度慢阻肺“安静区”气道病变,或可预测慢阻肺加速进展。

研究设计与样本

  • 多中心、基于人群的纵向CanCOLD研究,纳入从不吸烟者286例、高危吸烟者298例、GOLD I期361例和GOLD II期239例。
  • 第1次访视行吸气和呼气CT,6年内4次访视进行肺功能检查。

主要发现

  • 调整低衰减区(<-950 HU)后,GOLD I和II期TAC较从不吸烟者降低19%(P<0.0001),较高危者降低17%(P<0.0001)。
  • 缺失子代分支的父级气道内径更小(P<0.0001)且管壁更薄(P<0.0001)。
  • TAC对FEV1、FEV1/FVC和支气管舒张反应性的影响最大(均P<0.0001)。
  • TAC与肺功能下降独立相关(FEV1 P=0.02;FEV1/FVC P=0.01)。

临床怎么用

  • 商用软件测量CT总气道计数或可作为预测慢阻肺进展的生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Studies of excised lungs show that significant airway attrition in the "quiet" zone occurs early in chronic obstructive pulmonary disease (COPD). OBJECTIVES: To determine if the total number of airways quantified in vivo using computed tomography (CT) reflects early airway-related disease changes and is associated with lung function decline independent of emphysema in COPD. METHODS: Participants in the multicenter, population-based, longitudinal CanCOLD (Canadian Chronic Obstructive Lung Disease) study underwent inspiratory/expiratory CT at visit 1; spirometry was performed at four visits over 6 years. Emphysema was quantified as the CT inspiratory low-attenuation areas below -950 Hounsfield units. CT total airway count (TAC) was measured as well as airway inner diameter and wall area using anatomically equivalent airways. MEASUREMENTS AND MAIN RESULTS: Participants included never-smokers (n = 286), smokers with normal spirometry at risk for COPD (n = 298), Global Initiative for Chronic Obstructive Lung Disease (GOLD) I COPD (n = 361), and GOLD II COPD (n = 239). TAC was significantly reduced by 19% in both GOLD I and GOLD II compared with never-smokers (P < 0.0001) and by 17% in both GOLD I and GOLD II compared with at-risk participants (P < 0.0001) after adjusting for low-attenuation areas below -950 Hounsfield units. Further analysis revealed parent airways with missing daughter branches had reduced inner diameters (P < 0.0001) and thinner walls (P < 0.0001) compared with those without missing daughter branches. Among all CT measures, TAC had the greatest influence on FEV1 (P < 0.0001), FEV1/FVC (P < 0.0001), and bronchodilator responsiveness (P < 0.0001). TAC was independently associated with lung function decline (FEV1, P = 0.02; FEV1/FVC, P = 0.01). CONCLUSIONS: TAC may reflect the airway-related disease changes that accumulate in the "quiet" zone in early/mild COPD, indicating that TAC acquired with commercially available software across various CT platforms may be a biomarker to predict accelerated COPD progression.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Kirby M, Tanabe N, Tan WC, et al. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study. Am J Respir Crit Care Med. 2018. PMID: 28886252. doi:10.1164/rccm.201704-0692OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。